Over The Counter Stocks

[Value_Investor]

LGTT is up over 33.33% so far! Easy to surge over its 52-week-high 0.0020 based on 52M shares Huge Shorting position and less than 400M shares of the FIXED Tiny float available for trading!

This diamond-in-rough has the Largest Shorting position among all its 0.0001-Bottom OTC peers!

This hidden gem is Super Undervalued now comparing to its 0.0001-Bottom OTC peers (such as INND and AFTC etc.)!

To match the Same market value with INND at 0.098, LGTT will create a New 52-week high 0.167 which is 1,670 Times of its bottom price 0.0001!

To match the Same market value with AFTC at 0.0038, LGTT will create a New 52-week high 0.091 which is 910 Times of its bottom price 0.0001!

So LGTT is much much much cheaper than INND, DKMR, and AFTC now!

This hidden gem was most recently Upgraded to the Pink Sheet market from previous Toxic Grey Sheet just like its Similar-SS peer CIVX did in April of 2020! Note, this event had already driven CIVX to 0.0055 from the Same Bottom!

LGTT is also at Hyper Oversold status --- from 0.0020 to 0.0003!

[Value_Investor]

KGRI is up 66.67% now! Extremely Oversold --- from 0.0015 to 0.0003!

Easy to Double to hit 0.0006 from its New bottom 0.0003...

Note, KGRI has 27%-Higher OS count than LGTT though both have the Same AS counts!

LGTT has 52-weekk-high 0.0020 v.s. KGRI has 0.0015!

So at their New bottoms 0.0003 LGTT is much much cheaper than KGRI! Wow, LGTT is much much much cheaper than DKMR!

[fink]

Still looking for an established low float American pot play that has killer weed but geared to edibles. Non Cali company too.

[Value_Investor]

MDCE is up 16.67% so far! Extremely Oversold --- from 0.0029 to 0.0004!

Easy to Double to hit 0.0008 again from the New bottom 0.0004...

Note, both MDCE and LGTT have the Same OS counts!

At their peaks (0.0029 and 0.0020 respectively) and current price levels (0.0007 ~ 0.0004 and 0.0005 ~ 0.0003 respectively) LGTT is much much cheaper than MDCE and WKSP!

[ProfitScout]

$DKMR News: XFC Pleased with New Opponent Options for Tom O'Connor for Lightweight Tournament After Kenny Cross Withdraws Due to Injury

DESTIN, FL / ACCESSWIRE / March 5, 2021 / Kenny "The Boss" Cross has been forced to withdraw from his upcoming Xtreme Fighting Championships Lightweight Tournament Semifinal bout against Tom O'Connor.

A winner of six straight, Cross is regarded as one of the XFC's most exciting and dangerous fighters after scoring an impressive KO over Jarel Askew at XFC 43 on NBC Sports Network in November. XFC President Myron Molotky wishes Cross well in his recovery and tells fans that a new opponent for O'Connor should officially be announced next week: "First and foremost, the whole XFC family wishes Kenny a quick and complete recovery. The Hexagon is waiting for this young stud when he's back to 100-percent, and we know he's going to come back stronger than ever. That being said, our matchmakers have done an excellent job in securing several terrific new contenders for this opening in the XFC's Lightweight Tournament, and we can't wait to let our fans know which athlete will be awarded this opportunity."

About XFC

Xtreme Fighting Championships, Inc. (formerly Duke Mountain Resources, Inc.) is the first publicly traded premier international mixed martial arts ("MMA") organization with offices throughout the United States and South America, trading under the ticker symbol (OTC PINK:DKMR). Xtreme Fighting Championships ("XFC") is now partnered with NBC Sports in the United States, and has previously been carried on some of the largest open television broadcasters in Latin America - Rede TV! as well as HBO, ESPN, Esportes Interativo, Terra TV (the largest internet portal in the world), and UOL - the largest internet portal in Latin America, and premium cable & satellite television network. The XFC has had over 185 exclusively signed fighters, representing over 35+ countries worldwide with even more growth expected. Boasting the signing of The Next Generation of Male & Female Superstars, the XFC is known for entertaining fans with the most action packed MMA events both on television and in stadium venues. The Next Generation of MMA.

Press Contact:
Jen Wenk, APR
[e-mail]
208.421.2919

SOURCE: Xtreme Fighting Championships, Inc.



View source version on accesswire.com:
https://www.accesswire.com/633630/XFC-Pleased-with-New-Opponent-Options-for-Tom-OConnor-for-Lightweight-Tournament-After-Kenny-Cross-Withdraws-Due-to-Injury

[fink]

Wksp still has a ways to go. CSE is not going to be an option per HMFIC.
So it’s a slow wait on future Qs

What the story behind ICBT other than bloated and dirt cheap stock.
I might throws grand or two at it for kicks and giggles.
Is there a back story? R/M R/S? Billion share Bloated Beauties always keeps you on your toes. Easy to trade them for free shares. Then who cares what they do . Free= no risks , but I’ve already hit $400k for 2021 and not paying 70% plus State tax to anyone.

I need a hobby for the rest of the year

[Value_Investor]

ICBT is Extremely Undervalued now! 17-Bagger Huge rally last month! Easy Quick Double from here...

ICBT just did 2.4-Bagger Quick rally last week --- from 0.0005 to 0.0012!



WKSP is too expensive comparing to LGTT based on their current MV!

[fink]

You see WKSP yesterday?
That’s going to be an All Start play even after this .04 to over .50 runs it makes.
It’s going over multiple dollars in the next 18 months.
It’s a good play too till then

I’d play if for more shares than flipping for the cash. The key to that is to build a pile.

I’ve owned LGTT twice now. I’m loading pot plays as they trend down.,

[Value_Investor]

LGTT is up 25% so far! Easy to surge over its 52-week-high 0.0020 based on 51M shares Huge Shorting position and less than 400M shares of the FIXED Tiny float!

This diamond-in-rough has the Largest Shorting position among all its 0.0001-Bottom OTC peers!

LGTT is Super Undervalued now comparing to its 0.0001-Bottom OTC peers (such as INND and AFTC etc.)!

To match the Same market value with INND at 0.098, LGTT will create a New 52-week high 0.167 which is 1,670 Times of its bottom price 0.0001!

So LGTT is much much much cheaper than INND and AFTC now!

This hidden gem was most recently Upgraded to the Pink Sheet market from previous Toxic Grey Sheet just like its Similar-SS peer CIVX did in 2020! Note, this event had already driven CIX to 0.0055 from the Same Bottom!

LGTT is also at Hyper Oversold status --- from 0.0020 to 0.0004!

[Value_Investor]

FRCN is still at Extremely Oversold status though it is up 25% from its New bottom 0.0004! Easy to hit 0.0010 again like its Similar-SS peer (MNVN) did yesterday...

LGTT has Similar-SS with MNVN and FRCN but with an Huge Shorting position --- 51M shares which will generate an Huge Shorting-Squeezing effect like GME had several weeks ago...

[ProfitScout]

$DKMR News & Limited Time Ticket Opportunity: XFC Officially Releases Tickets On Sale For YoungGuns 1, March 27 at FireLake Arena in Shawnee, OK

DESTIN, FL / ACCESSWIRE / February 26, 2021 / Tickets are now on sale for Xtreme Fighting Championships' (OTC PINK:DKMR) YoungGuns 1, which takes place March 27 at FireLake Arena in Shawnee, OK, as a part of The XFC Experience Week.

Tickets for YoungGuns 1 are available here: https://www.stubwire.com/event/xfcyoungguns1/firelakearenaandeventcenter/shawnee/23203/

YoungGuns 1 will be headlined by a middleweight battle between Oklahoma standouts Braden Smith (10-4) and Franklin Patterson (6-5), and Michigan's Austin Bashi (1-0) returns to the Hexagon against California's Mason Iacobellis (1-0) in the Co-Main Event. Oklahoma's Kristina "Warhorse" Williams makes her highly anticipated Hexagon debut against Helen Lucero.

After making his XFC debut in November, Las Vegas' own Enzo Perez makes his highly anticipated return to the Hexagon to battle Oklahoma's Tony Clanton at 135 pounds. Kris "The Problem" Vereen (3-0, all finishes) & Rico Cato (3-3, all finishes) make their Hexagon debuts in a battle of powerful Oklahoma welterweights. One of Oklahoma's best amateur contenders, Jared Ray, tries to improve to 6-0 versus his toughest challenge yet, Chicago's Datrelle Kozeluh (7-2-2) at 130 pounds. Undefeated Oklahoma fighter Jared Brown takes aim at his next target, Michigan's Jesse Robertson, when they lock horns at 145 pounds.

XFC President Myron Molotky on YoungGuns 1 on March 27 in Shawnee, OK: "This is a must-see event for combat sports fans worldwide.. We have 15 YoungGuns bouts featuring the most exciting young fighters in the game. The XFC Matchmakers have scoured the globe for fighters ready to announce their presence when they step into the Hexagon with an opportunity to showcase their world-class skills on our global platform."

About XFC

Xtreme Fighting Championships, Inc. (formerly Duke Mountain Resources, Inc.) is the first publicly traded premier international mixed martial arts ("MMA") organization with offices throughout the United States and South America, trading under the ticker symbol DKMR. Xtreme Fighting Championships ("XFC") is now partnered with NBC Sports in the United States, and has previously been carried on some of the largest open television broadcasters in Latin America - Rede TV! as well as HBO, ESPN, Esportes Interativo, Terra TV (the largest internet portal in the world), and UOL - the largest internet portal in Latin America, and premium cable & satellite television network. The XFC has had over 185 exclusively signed fighters, representing over 35+ countries worldwide with even more growth expected. Boasting the signing of The Next Generation of Male & Female Superstars, the XFC is known for entertaining fans with the most action packed MMA events both on television and in stadium venues. The Next Generation of MMA.

Press Contact:

Jen Wenk, APR
[e-mail]
208.421.2919

SOURCE: Xtreme Fighting Championships, Inc.



View source version on accesswire.com:
https://www.accesswire.com/632304/XFC-Officially-Releases-Tickets-On-Sale-For-YoungGuns-1-March-27-at-FireLake-Arena-in-Shawnee-OK

[Value_Investor]

MNVN is Super Undervalued now! Hyper Oversold --- from 0.0018 to 0.0005! Easy Quick Triple from here...

MNVN is much much much cheaper than AXXA now!

[Value_Investor]

ORMTQ is the Cheapest CH11-CLEAN-Shell with the FIXED Sought-After Super Tiny SS! A ideal Reverse-Merger candidate or Custodianship-Taking-Over target...

Easy to shoot the Dime Land based on its peer's market value! Huge potential to hit the Dollar Land in the short term!

Its peer ALLMQ (the New symbol is "ALLM", 245,865,278/500M shares Large OS/AS) did run 36.4-Bagger from $0.0022 to $1.5 within only several months! To match the Same market value, ORMTQ (18,662,272/100M shares Small OS/AS) will create a New Record-High $19.7617 v.s. at Giant discount price $0.0135 now!

Buying its peer CBLAQ at 0.33 = buying ORMTQ at $3.4759!

[ProfitScout]

$SMME: Crypto Currency transactions are on the fastest growing edge of the banking and finance sector today and this trend is only going to accelerate in the coming years.

SmartMetric the Maker of Biometric Secured Credit and Debit Cards Is to Introduce a Stable Crypto Currency Key Storage on Its Biometric Card Platform

NEW YORK--(BUSINESS WIRE)-- SmartMetric, Inc. (OTCQB: SMME) -- In light of the payments and credit card industry move into adopting crypto currency technology to facilitate payments, SmartMetric has now moved forward its planned release of its crypto key storage technology for use with credit and debit cards.

“For a number of years we have been working on an engineered solution to bring together the power of biometric card based security, large scale encrypted memory incorporated into an existing credit and debit card format,” said today SmartMetric’s President & CEO, Chaya Hendrick.

Now that one of the major payment cards networks has announced its move into Government approved stable crypto, SmartMetric is now able to offer a card platform that has embedded inside the card a biometric fingerprint scanner for validating the card user and automatically giving the validated user access to the encrypted crypto keys stored inside the new SmartMetric Crypto Payments Card.

The SmartMetric Crypto Card solution has its own crypto key secure element inside the card protected by firewalled encryption. This allows for the safe storage on the card of encrypted crypto keys in a highly functional manner.

SmartMetric has built inside its crypto payments card significant memory along with a crypto engine inside a secure element chip separate from the secure element used to perform credit and debit card transactions. By having two separated firewalled secure elements we are able to provide a much higher security than current card architecture provides while also providing greater memory and added encryption power.

The SmartMetric biometric fingerprint activated credit/debit card is easy to use and allows an easy to enroll of a person’s fingerprint. The card holder’s fingerprint is stored and encrypted inside the SmartMetric biometric card in a one-time touch and store process. Similar to the simplicity and ease of storing a fingerprint on a mobile phone. SmartMetric secure user storage of the cardholder's fingerprint does not require additional fingerprint reading devices in Bank branches for enrolling fingerprints. This allows the SmartMetric biometric card solution to be easily used by mass card issuers without having to change their distribution methods.

This video link shows the simple and secure fingerprint enrollment process for the card user. FINGERPRINT CARD ENROLLMENT

Biometric security used to activate the credit/debit card provides a much more enhanced level of security beyond the simple four-digit PIN. This enhanced security represents a major advance in the protection of card holders and card issuing banks alike.

The current manufacturing capacity of the SmartMetric biometric credit/debit card is in excess of 1 million cards a month.

An independent research company has projected that estimated biometric credit/debit cards worldwide over the next few years will exceed 500 million cards. According to industry figures, over 9 billion credit/debit chip based cards have been issued globally.

SmartMetric is a USA based company with sales and marketing partnerships in Latin America, Europe the United Stated. Engineering of the biometric card electronics is done in-house and is the owned intellectual property of the company.

To view the SmartMetric Biometric Card please follow this link - Video of the SmartMetric Biometric Card. To view the company website: http://www.smartmetric.com

Figures provided by the Nilson Report and Goode Intelligence

Safe Harbor Statement: Forward-Looking Statements in this press release, which are not historical facts, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Also such forward-looking statements are within the meaning of that term in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Our actual results, performance or achievements may differ materially from those expressed or implied by these forward-looking statements. In some cases, you can identify forward-looking statements by the use of words such as "may," "could," "expect," "intend," "plan," "seek," "anticipate," "believe," "estimate," "predict," "potential," "continue," "likely," "will," "would" and variations of these terms and similar expressions, or the negative of these terms or similar expressions. Such forward-looking statements are necessarily based upon estimates and assumptions that, while considered reasonable by us and our management, are inherently uncertain. Factors that may cause actual results to differ materially from current expectations include, among others, if we are unable to access the capital necessary to fund current operations or implement our plans for growth; changes in the competitive environment in our industry and the markets where we operate; our ability to access the capital markets; and other risks discussed in the Company's filings with the U.S. Securities and Exchange Commission, including our Annual Report on Form 10-K, which filings are available from the SEC. We caution you not to place undue reliance on any forward-looking statements, which are made as of the date of this press release. We undertake no obligation to update publicly any of these forward-looking statements to reflect actual results, new information or future events, changes in assumptions or changes in other factors affecting forward-looking statements, except to the extent required by applicable laws. If we update one or more forward-looking statements, no inference should be drawn that we will make additional updates with respect to those or other forward-looking statements. Investors and security holders are urged to carefully review and consider each of SmartMetric Inc. public filings with the SEC, including but not limited to, if applicable, Annual Reports on Form 10-K, proxy statements, Current Reports on Form 8-K and Quarterly Reports on Form 10-Q.

https://cts.businesswire.com/ct/CT?id=bwnews&sty=20201210006066r1&sid=acqr8&distro=nx&lang=en
View source version on businesswire.com: https://www.businesswire.com/news/home/20201210006066/en/

SmartMetric, Inc.
Chaya Hendrick
President & CEO
3960 Howard Hughes Parkway, Suite 500
Las Vegas, Nevada. 89169 USA
Tel: [phone]
[e-mail]
http://www.smartmetric.com

Source: SmartMetric, Inc.

[Value_Investor]

MDCE is up 11.11% now! Extremely Oversold --- from 0.0029 to 0.0007!

Easy to Double to hit 0.0014 again...

Note, both MDCE and LGTT have almost the Same OS counts (3B shares)!

At their peaks and current price levels LGTT is much much cheaper than MDCE!

[Value_Investor]

TONR is on Big Fire today! Up 50% from the New bottom support 0.0006! Easy to test its most recent high 0.0018 again!

To match the Same market value with its Same-Bottom and Similar-SS peer PUGE (4.75B/5B shares OS/AS) at 0.0095, TONR will create a New 52-week high 0.0663 which is 663 Times of its bottom price 0.0001!

So TONR is much much much cheaper than its peer PUGE now!

[ProfitScout]

$DKMR: Kristina Williams, Helen Lucero Set For Women’s MMA Showdown At YoungGuns 1 on March 27 in Shawnee, OK

DESTIN, FL / ACCESSWIRE / February 24, 2021 / Kristina "Warhorse" Williams and Helen Lucero will clash at the Xtreme Fighting Championships' inaugural YoungGuns event, March 27 at FireLake Arena in Shawnee, OK.

Williams, a proud product of the Sooner State, makes her Hexagon debut in her native Oklahoma after starting her professional career with six fights under the Bellator MMA banner. Lucero makes her XFC debut after scoring a submission victory in her most recent bout in her native Colorado.

XFC President Myron Molotky on today's fight news: "The XFC has a proud history of promoting some of the most exciting and competitive women's MMA matches in the world, and this is a fight we're really excited about. Both of these athletes are hungry to take advantage of this opportunity to introduce themselves to a global audience under the XFC's YoungGuns banner."

YoungGuns 1 takes place March 27 at FireLake Arena in Shawnee, OK as a part of the inaugural XFC Experience Week. YoungGuns 1 will be headlined by a middleweight battle between Oklahoma standouts Braden Smith (10-4) and Franklin Patterson (6-5), and Michigan's Austin Bashi (1-0) returns to the Hexagon against California's Mason Iacobellis (1-0) in the Co-Main Event.

About XFC
Xtreme Fighting Championships, Inc. (formerly Duke Mountain Resources, Inc.) is the first publicly traded premier international mixed martial arts ("MMA") organization with offices throughout the United States and South America, trading under the ticker symbol DKMR. Xtreme Fighting Championships ("XFC") is now partnered with NBC Sports in the United States, and has previously been carried on some of the largest open television broadcasters in Latin America - Rede TV! as well as HBO, ESPN, Esportes Interativo, Terra TV (the largest internet portal in the world), and UOL - the largest internet portal in Latin America, and premium cable & satellite television network. The XFC has had over 185 exclusively signed fighters, representing over 35+ countries worldwide with even more growth expected. Boasting the signing of The Next Generation of Male & Female Superstars, the XFC is known for entertaining fans with the most action packed MMA events both on television and in stadium venues. The Next Generation of MMA.

Press Contact:
Jen Wenk, APR
[e-mail]
208.421.2919

SOURCE: Xtreme Fighting Championships, Inc.



View source version on accesswire.com:
https://www.accesswire.com/631533/Kristina-Williams-Helen-Lucero-Set-For-Womens-MMA-Showdown-At-YoungGuns-1-on-March-27-in-Shawnee-OK

[Value_Investor]

LGTT is up 33.33% so far! Easy to surge over its 52-week-high 0.0020 based on 51M shares Huge Shorting position alone!

This diamond-in-rough has the Largest Shorting position among all its 0.0001-Bottom OTC peers!

To match the Same market value with INND at 0.098, LGTT will create a New 52-week high 0.1398 which is 1,398 Times of its bottom price 0.0001!

LGTT is much much much cheaper than INND and SPRWF now!

[ProfitScout]

$SBFM: Sunshine Biopharma Discusses the Progress of Its COVID-19 and Anticancer Compounds with The Stock Day Podcast
Click here:
https://www.newsfilecorp.com/release/74719/Sunshine-Biopharma-Discusses-the-Progress-of-Its-COVID19-and-Anticancer-Compounds-with-The-Stock-Day-Podcast

About Sunshine Biopharma

In addition, to working on the development of a treatment for COVID-19, Sunshine Biopharma is engaged in the development Adva-27a, a unique anticancer compound. Tests conducted to date have demonstrated the effectiveness of Adva-27a at destroying Multidrug Resistant Cancer Cells, including Pancreatic Cancer cells, Small-Cell Lung Cancer cells, Breast Cancer cells, and Uterine Sarcoma cells. Clinical trials for Pancreatic Cancer indication are planned to be conducted at McGill University's Jewish General Hospital in Montreal, Canada. Sunshine Biopharma is owner of all patents and intellectual property pertaining to Adva-27a.

[Value_Investor]

FRCN is Extremely Oversold today! Easy 100% Quick bounce to 0.0010 from today's low 0.0005 in the next week...

LGTT has Similar-SS with FRCN but with an Huge Shorting position --- 51M shares which will generate an Huge Shorting-Squeezing effect like GME had this month...

[Value_Investor]

ICBT is Extremely Undervalued now! 17-Bagger Huge rally from its Bottom! Easy Quick Double from here...

ICBT is much much much cheaper than SPRWF, MINE, and RITE now!

[Zardiw]

#DDAmanda Chart (CLASSIC Insider Play) on: $FBCD :

You can find these before they run:



What the Fact (Factor) Column is:

The Factor is a proprietary indicator used for scanning in #DDAmanda.

It's defined as Today's $Traded divided by the average daily $Traded (20 day avg).

SO, if a stock has say a 10 Factor that day, it means she traded 10 Times the $ she normally trades.

That's significant, and many times indicates that a run in the stock is coming.

Previous Charts: $AVXL, $JNSH, $NWBO, $CYDY, $AMRN, $ENZC, $TSNP, $HCMC, $FNMA, $TPII

z

[fink]

SPRWF .40 pot stock got excellent revenue report after hour.
Worth a look. Pot is hot.

DC wants to legalize it. That’s just a matter of time. SPRWF has a killer facility and doesn’t need the US to stay alive. The US is going to push this .40 stock above $4.00

After this stupid impeachment, DC has nothing to offer Anerica. Pot is going to be it to lift them from tgst embarrassing show of “Unity”.

I’m accumulating


https://investorshub.advfn.com/boards/read_msg.aspx?message_id=161759558

[Value_Investor]

WDSL is Super Undervalued now! The diamond-in-rough has the Lowest OS count forever --- mere 200,760 shares!

This hidden gem is heading onto Multiple Dozens Of Dollars now...

[Value_Investor]

ORMTQ is the Cheapest CH11-CLEAN-Shell with the FIXED Sought-After Super Tiny SS! A ideal Reverse-Merger candidate or Custodianship-Taking-Over target...

Easy to shoot the Dime Land based on its peer's market value! Huge potential to hit the Dollar Land in the short term!

Its peer ALLMQ (the New symbol is "ALLM", 245,865,278/500M shares Large OS/AS) did run 36.4-Bagger from $0.0022 to $1.5 within only several months! To match the Same market value, ORMTQ (18,662,272/100M shares Small OS/AS) will create a New Record-High $19.7617 v.s. at 99.953% Giant discount price $0.0094 now!

[Value_Investor]

MNVN is up 60% so far! Super Undervalued now! Easy 10-Bagger Quick rally from its Bottom 0.0001!

MNVN is much much much cheaper than TSNP, MINE, PUGE, and RITE now!

[Value_Investor]

FRCN is up 75% today! Hyper Oversold --- from 0.0024 to 0.0001 within only a couple of weeks! Easy to hit 0.0010 in the coming days...

FRCN is much much cheaper than SNPW now!

[Value_Investor]

ICBT is up 20% so far! Extremely Undervalued now! Easy 10-Bagger Quick rally from its Bottom!

ICBT is much much much cheaper than SGTM, MINE, and RITE now!

[Value_Investor]

TONR is on Big Fire today! Up 20% from the New bottom support 0.0005! Easy to break up its recent high 0.0025 again!

To match the Same market value with its Same-Bottom and Similar-SS peer PUGE (3.5B+/5B shares OS/AS) at 0.0060, TONR will create a New 52-week high 0.0308 which is 308 Times of its bottom price 0.0001!

So TONR is much much much cheaper than its peers PUGE and ALYI etc. now!

[Value_Investor]

MDCE is up 25% so far! Extremely Oversold --- from 0.0007 to 0.0002!

Huge potential to run 11-Bagger Quick rally from current joke low price (0.0005)...

To match the Same market value with its peer CIVX at 0.0055, MDCE will create a New 52-week high 0.0055 which is 55 Times of its Bottom price 0.0001!

Note, both MDCE and CIVX have almost the Same OS counts.

So MDCE is much much much cheaper than AXXA and CIVX now!

[ProfessorM]

$AXXA +10.17% good day all day, keep an eye on it
https://stockcharts.com/h-sc/ui?s=axxa

[Value_Investor]

LGTT is up 25% so far! Easy to hit last week's high 0.0012 again...

LGTT is much much cheaper than ZAGG, RITE, RDWD, ILST, and FBCD etc. peers now!

[Value_Investor]

ORMTQ is On Fire today! It will be very easy to hit 0.018 again based on measly 18M shares of the FIXED Super Tiny OS count...

[ProfitScout]

$SBFM Sunshine Biopharma Completes Application to Uplist to OTCQB

MONTREAL, QC / ACCESSWIRE / January 27, 2021 / Sunshine Biopharma Inc. (OTC PINK:SBFM), a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral drugs, today announced that it has successfully completed and submitted the application to uplist to the OTCQB. While the Company is currently a fully reporting issuer trading on OTC Markets PINK, management has determined that an uplist to OTCQB is aligned with the Company's overall growth trajectory as it will allow institutional investors to participate.

https://www.accesswire.com/users/newswire/images/626135/SUNSHINEBIO-LOGO111820.jpg

The OTCQB Venture Market, operated by OTC Markets Group Inc. in New York City, is a premier market for early stage and developing companies. As a verified market with efficient access to U.S. investors, OTCQB helps companies build shareholder value with a goal of enhancing liquidity and achieving fair valuation.

Sunshine Biopharma's CFO, Camille Sebaaly, stated, "Joining the OTCQB is a pivotal milestone for the Company and elevates Sunshine's reputation among the investment community. We would like to thank our shareholders for their continued support as the Company has been steadily growing and making advancements in research and development."

About Sunshine Biopharma's Coronavirus Treatment
Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) is the causative agent of the ongoing COVID-19 pandemic that has claimed the lives of over 1.4 million people worldwide since it first appeared in December 2019. There are currently no drugs that can effectively arrest replication of the virus in people who have contracted the illness. On May 22, 2020, Sunshine Biopharma filed a provisional patent application for several molecules which were designed by computer-aided modeling to inhibit the Coronavirus proteases, thus shutting down the ability of the virus to multiply. Sunshine Biopharma has since completed the synthesis of four such molecules and identified a lead compound, SBFM-PL4. In collaboration with the University of Georgia, College of Pharmacy, the Company is currently advancing the development of SBFM-PL4 through the in vitro testing stage to be followed by mice studies before entering clinical trials on COVID-19 patients.

About Sunshine Biopharma
In addition, to working on the development of a treatment for COVID-19, Sunshine Biopharma is engaged in the development Adva-27a, a unique anticancer compound. Tests conducted to date have demonstrated the effectiveness of Adva-27a at destroying Multidrug Resistant Cancer Cells, including Pancreatic Cancer cells, Small-Cell Lung Cancer cells, Breast Cancer cells, and Uterine Sarcoma cells. Clinical trials for Pancreatic Cancer indication are planned to be conducted at McGill University's Jewish General Hospital in Montreal, Canada. Sunshine Biopharma is owner of all patents and intellectual property pertaining to Adva-27a.

Safe Harbor Forward-Looking Statements
This press release may contain forward looking statements which are based on current expectations, forecasts, and assumptions that involve risks as well as uncertainties that could cause actual outcomes and results to differ materially from those anticipated or expected, including statements related to the amount and timing of expected revenues statements related to our financial performance, expected income, distributions, and future growth for upcoming quarterly and annual periods. These risks and uncertainties are further defined in filings and reports by the Company with the U.S. Securities and Exchange Commission (SEC). Actual results and the timing of certain events could differ materially from those projected in or contemplated by the forward-looking statements due to a number of factors detailed from time to time in our filings with the SEC. Among other matters, the Company may not be able to sustain growth or achieve profitability based upon many factors including but not limited to general stock market conditions. Reference is hereby made to cautionary statements set forth in the Company's most recent SEC filings. We have incurred and will continue to incur significant expenses in our expansion of our existing as well as new service lines noting there is no assurance that we will generate enough revenues to offset those costs in both the near and long term. Additional service offerings may expose us to additional legal and regulatory costs and unknown exposure(s) based upon the various geopolitical locations we will be providing services in, the impact of which cannot be predicted at this time.

For Additional Information Contact:
Camille Sebaaly, CFO
Sunshine Biopharma Inc.
Direct Line: 514-814-0464
[e-mail]
http://www.sunshinebiopharma.com

SOURCE: Sunshine Biopharma Inc.

[Value_Investor]

TONR is on Big Fire today! Up 100% from the New bottom 0.0003! Easy to hit 0.0014 again!

To match the Same market value with its Same-Bottom and Similar-SS peer PUGE (3.5B+/5B shares OS/AS) at 0.0060, TONR will create a New 52-week high 0.0309 which is 309 Times of its bottom price 0.0001!

So TONR is much much much cheaper than its peers BTIM and PUGE now!

[Value_Investor]

ICBT is on Big Fire today! Up over 33.33% so far! Easy 10-Bagger Quick rally!

ICBT is much much much cheaper than ZAAG and MINE now!

[Value_Investor]

FRCN was up 20% yesterday! Hyper Oversold --- from 0.0024 to 0.0001 within only a couple of weeks! Easy to hit 0.0010 in the coming week...

Both FRCN and its peer RITE have almost the Same Maximal trading volume (600M shares) in history and Similar 52-week-high --- 0.0024 vs 0.0020!

Both RITE and FRCN are much much much cheaper than SWRM now!

[ProfitScout]

$SBFM is well funded to deliver its vitally needed Coronavirus Treatment.

Sunshine Biopharma Receives Fourth Tranche From Previously Announced $2,000,000 + Financing for Coronavirus Treatment

MONTREAL, QC / ACCESSWIRE / January 14, 2021 / Sunshine Biopharma Inc. (OTC PINK:SBFM), a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral drugs, today announced that it has received the fourth tranche of funding under the recently announced committed minimum financing of $2,000,000 with RB Capital Partners Inc. This brings the total to $1,050,000 that the Company has received to date under this financing. The proceeds will be used for the ongoing development of the Company's Coronavirus Treatment on a priority basis and the clinical development of Adva-27a, the Company's flagship anticancer compound targeted for pancreatic cancer.

https://www.accesswire.com/users/newswire/images/624274/SUNSHINEBIO-LOGO111820.jpg

Sunshine Biopharma Inc. CFO, Camille Sebaaly stated, "As a company, we continue to forge forward in our development of a COVID treatment and our anticancer compounds. This investment capital has been integral to our progress in each of these sectors."

Brett Rosen and Deborah Braun of RB Capital Partners Inc. stated, "We are very impressed with the Sunshine leadership team and their commitment to developing critical life-saving medical treatments. Our investment money has been met with ongoing milestones and we are pleased to be considered a long-term funding partner of the Company. We are looking forward to a potential up-list to the Nasdaq in the future."

About Sunshine Biopharma's Coronavirus Treatment
Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) is the causative agent of the ongoing COVID-19 pandemic that has claimed the lives of over 1.9 million people worldwide since it first appeared in December 2019. There are currently no drugs that can effectively arrest replication of the virus in people who have contracted the illness. On May 22, 2020, Sunshine Biopharma filed a provisional patent application for several molecules which were designed by computer-aided modeling to inhibit the Coronavirus proteases, thus shutting down the ability of the virus to multiply. Sunshine Biopharma has since completed the synthesis of four such molecules and identified a lead compound, SBFM-PL4. In collaboration with the University of Georgia, College of Pharmacy, the Company is currently advancing the development of SBFM-PL4 through the in vitro testing stage to be followed by mice studies before entering clinical trials on COVID-19 patients.

About Sunshine Biopharma
In addition, to working on the development of a treatment for COVID-19, Sunshine Biopharma is engaged in the development Adva-27a, a unique anticancer compound. Tests conducted to date have demonstrated the effectiveness of Adva-27a at destroying Multidrug Resistant Cancer Cells, including Pancreatic Cancer cells, Small-Cell Lung Cancer cells, Breast Cancer cells, and Uterine Sarcoma cells. Clinical trials for Pancreatic Cancer indication are planned to be conducted at McGill University's Jewish General Hospital in Montreal, Canada. Sunshine Biopharma is owner of all patents and intellectual property pertaining to Adva-27a.

Safe Harbor Forward-Looking Statements
This press release may contain forward looking statements which are based on current expectations, forecasts, and assumptions that involve risks as well as uncertainties that could cause actual outcomes and results to differ materially from those anticipated or expected, including statements related to the amount and timing of expected revenues statements related to our financial performance, expected income, distributions, and future growth for upcoming quarterly and annual periods. These risks and uncertainties are further defined in filings and reports by the Company with the U.S. Securities and Exchange Commission (SEC). Actual results and the timing of certain events could differ materially from those projected in or contemplated by the forward-looking statements due to a number of factors detailed from time to time in our filings with the SEC. Among other matters, the Company may not be able to sustain growth or achieve profitability based upon many factors including but not limited to general stock market conditions. Reference is hereby made to cautionary statements set forth in the Company's most recent SEC filings. We have incurred and will continue to incur significant expenses in our expansion of our existing as well as new service lines noting there is no assurance that we will generate enough revenues to offset those costs in both the near and long term. Additional service offerings may expose us to additional legal and regulatory costs and unknown exposure(s) based upon the various geopolitical locations we will be providing services in, the impact of which cannot be predicted at this time.

For Additional Information Contact:
Camille Sebaaly, CFO
Sunshine Biopharma Inc.
Direct Line: 514-814-0464
[e-mail]
http://www.sunshinebiopharma.com

SOURCE: Sunshine Biopharma Inc.

View source version on accesswire.com:
https://www.accesswire.com/624274/Sunshine-Biopharma-Receives-Fourth-Tranche-From-Previously-Announced-2000000-Financing-for-Coronavirus-Treatment

[madeindet]

SWRM ready for next leg up chart screaming buy

[Value_Investor]

FBCD is up 50% today with Huge Slapping volumes! Ready to soar back to the Penny Land again...

To match the Same market value with its peer CIVX (3B+/5B shares OS/AS) at 0.0055, FBCD will create a New 52-week high 0.0115 which is 115 Times of its Bottom price!

So FBCD is much much much cheaper than CIVX now!

In fact its recent high 0.013 = 43.33+ Time of its current ridiculous low price 0.0003!

[Value_Investor]

RITE is up 50% today with the Largest Slapping volumes! The most recent high was 0.0020 several months ago! Today's high is 0.00044! It should be easy to test 52-week-high 0.0020 again since the FIXED SS is the Same and all its similar-SS peers exploded to similar levels nowadays...

RITE is much much much cheaper than GSFI now!

[Value_Investor]

CRRSQ is at Hyper Oversold status --- from 0.0415 to 0.0007! It only has 16M shares FIXED Super Tiny float which is the Lowest among the majority of its CH11-"Q" peers!

Easy to hit Multiple Pennies again with only a couple of millions share's Slapping volumes...

To match the Same MV with its CH11-peer CBLAQ at 0.07, CRRSQ will create a New high 0.0871 which is 109.88%-Higher than its New 52-week high 0.0415! Note, 0.0871 = 27.22 Times of its current ridiculous low price 0.0032!

So CRRSQ is much much much cheaper than CBLAQ now!

[BottomBounce]

$ALYI Rideshare market is over $50 billion and projected to reach $220 billion by 2025.
https://seekingalpha.com/instablog/21922151-bioresearch-alert/5354767-alyi-alternet-systems-turning-hemp-stronger-lighter-cars-and-powerful-batteries

[BottomBounce]

$IDEX Ideanomics The Co Is In The Commercial Fleet Operator Space

[ProfitScout]

$NGTF Enjoy Nightfood Tonight - Low Calorie, Great Tasting Ice Cream Formulated to Help Improve Sleep.

Nightfood Holdings, Inc. (OTC: NGTF), owns Nightfood, Inc. and MJ Munchies, Inc.

Nightfood has expanded distribution for its ice cream into major divisions of the largest supermarket chains in the United States: Kroger (Harris Teeter), Albertsons Companies (Jewel-Osco and Shaw's and Star Markets), and H-E-B (Central Market) as well as Lowe's Foods, Rouses Markets, and other independent retailers.

Nightfood won the 2019 Product of the Year award in the ice cream category in a Kantar survey of over 40,000 consumers. Nightfood was also named Best New Ice Cream in the 2019 World Dairy Innovation Awards.

Nightfood has been endorsed as the Official Ice Cream of the American Pregnancy Association and is the recommended ice cream for pregnant women. There are approximately 3,000,000 pregnant women in the United States at any given time, and ice cream is the single most-widely reported pregnancy craving. With more calcium, magnesium, zinc, prebiotic fiber, and casein protein, less sugar and a lower glycemic profile than regular ice cream, Nightfood has been identified as a better choice for expectant mothers.

Nightfood is not just for pregnant women. Over 80% of Americans snack regularly at night, resulting in an estimated 700M+ nighttime snack occasions weekly, and an annual spend on night snacks of over $50 billion dollars, the majority of it on options that are understood to be both unhealthy, and disruptive to sleep quality.

Nightfood was formulated by sleep and nutrition experts with ingredients that research suggests can support nighttime relaxation and better sleep quality. Scientific research indicates unhealthy nighttime cravings are driven by human biology. Willpower is also weakest at night, and stress is another contributing factor. A majority of night snackers report feeling both guilty and out-of-control when it comes to their nighttime snacking.

Because unhealthy night snacking is believed to be biologically driven, and not a trend or a fad, management sees significant opportunity in pioneering the category of nighttime-specific snacks for better sleep.

MJ Munchies, Inc. was formed in 2018 as a new, wholly owned subsidiary of Nightfood Holdings, Inc. to capitalize on legally compliant opportunities in the CBD and marijuana edibles and related spaces. The Company is seeking licensing opportunities to market such products under the brand name "Half-Baked", for which they've successfully secured trademark rights.

Questions can be directed to [e-mail]

[ProfessorM]

$GSFI released exciting news today! https://finance.yahoo.com/news/green-stream-holdings-prepares-ne-173600235.html

[snowden]

$ZAAG official website: https://www.eatatzen.com/, visit now

[Value_Investor]

MDCE is up 50% so far! Extremely Oversold --- from 0.0007 to 0.0002! Huge potential to run 16-Bagger Quick rally from current joke low price (0.0003)...

To match the Same market value with its peer CIVX (2.5B+/5B shares Huge/Giant OS/AS) at 0.0055, MDCE will create a New 52-week high 0.0047 which is 47 Times of its Bottom price 0.0001!

So MDCE is much much much cheaper than QBIO and CIVX now!

[Value_Investor]

LOCMQ is up 32.4% today! It will soon break out its current joke low 52-week-high 0.0199 based on meager 23M shares FIXED Super Tiny OS and 21M shares FIXED Super Tiny float!

At Hyper Oversold status --- from its Post-CH11-First-Bouncing-High 0.17 to its All-Time-Low 0.0001!

This CH11-CLEAN-shell is also Super Undervalued now --- mere $0.1M MV v.s. its CH7-peer (CERPQ) ever hit $7.5M MV most recently!

Easy 10-Bagger Quick rally from here (0.0050) to create Another New high 0.05 (i.e. $1.1M MV)...

To match the Same MV with CERPQ at 0.1, LOCMQ will hit 0.3203 which is 64.06 Times of its current price 0.0050!

[Value_Investor]

RCMH is on Huge Fire today! It is currently the Cheapest 0.0001-Bottom OTC stock! This hidden gem has CLEAN shell status! Very High Insider's Ownership! Ready to be acquired through a Reverse-Merger deal or Custodianship-Taking-Over by David Lazar etc....

RCMH will Easily And Quickly surge back to its recent high 0.0018 again based on only 851M shares FIXED Low OS count and less than 500M shares Small float count...

To match the same market value with its peer VIBI (2,960,023,326 shares OS) at 0.0053, RCMH will create a New 52-week high 0.01843 which is 184.3 Times of its Bottom price 0.0001!

To match the Same market value with its peer CIVX (2.5B+/5B shares Huge/Giant OS/AS) at 0.0055, RCMH will create a New 52-week high 0.0165 which is 165 Times of its Bottom price!

To match the Same market value with its peer PUGE (3B+/2.99B shares OS/AS) at 0.0040, RCMH will create a New 52-week high 0.0141 which is 141 Times of its bottom price 0.0001!

So RCMH is much much much cheaper than QBIO, VIBI, CIVX, and PUGE now!